Sign in
Taking people in Hong KongNo phase

Building a Diagnostic Rule for Acute Heart Failure in Emergency Departments

Builds a rule to help diagnose acute heart failure in emergency patients.

Key facts

Who runs it
Chinese University of Hong Kong
Where
Hong Kong, Hong KongSee the 3 sites
Trial code
Registry title
Comprehensive Clinical Prediction Rule for Acute Heart Failure
Status
Recruiting
People taking part
560 people, planned
Started
17 Aug 2026
Expected to end
31 Jan 2029
Type of study
Observational, 2 groups
Treatments tested
  • Acute Heart Failure Diagnostic Method
Record updated
5 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who come to the emergency department with suspected acute heart failure or sudden shortness of breath. It tests a combined way to diagnose acute heart failure.

Age
18 years and older
Sex
All sexes can join.
Disease stage
Suspected acute heart failure or acute shortness of breath (dyspnea). Symptoms include shortness of breath, swollen legs, difficulty breathing when lying flat, waking at night short of breath, breathlessness on exertion, or weight gain.

Main reasons for not taking part

  • Trauma patients
  • Pregnancy
  • Unstable patients who need invasive airway treatment
  • Patients who refuse to take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Adult (aged ≥ 18 years)
  • Suspected AHF or acute dyspnea
  • Symptoms include shortness of breath, swelling of legs, orthopnea, paroxysmal nocturnal dyspnoea, exertional dyspnea or weight gain

Who cannot take part

  • Trauma patients
  • Pregnancy
  • Unstable patients requiring invasive airway intervention
  • Patients who refuse to participate

Where in Hong Kong

  • Prince of Wales HospitalHong Kong, Hong KongContact: Theresa HuiTaking people
  • Queen Mary HospitalHong Kong, Hong KongContact: Rex PK Lam, Dr.Not yet recruiting
  • Tuen Mun HospitalHong Kong, Hong KongContact: Jeffrey HT Fung, Dr.Not yet recruiting

About the trial

What the trial wants to find out

The goal of this prospective observational cohort study is to establish a comprehensive clinical prediction rule integrating clinical characteristics, point-of-care testing (POCT) of NT-proBNP, an 8-point LUS, and a rapid cardiac assessment using bedside echocardiography for diagnosing acute heart failure (AHF) in the emergency department. A clinical prediction rule with high diagnostic accuracy will minimize delays and misdiagnoses, as well as the potential harm they may cause to patients. The primary outcome measure is the adjudicated AHF diagnosis. Secondary outcome measures include ED and discharge diagnosis of the patients.

The 2 groups in the trial

  • Testing Cohort

    Patients from PWH and TMH

    Treatment: Acute Heart Failure Diagnostic Method

  • Validation Cohort

    Patients from QMH

    Treatment: Acute Heart Failure Diagnostic Method

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Establishing a Comprehensive Clinical Prediction Rule for the Diagnosis of Acute Heart Failure in the Emergency Department
Plain-language title
Building a Diagnostic Rule for Acute Heart Failure in Emergency DepartmentsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
5 November 2026